by telrheum | May 1, 2024 | Autoimmune Diseases, Stress
The article, “Stressful Life Events in the Year Prior to Their Diagnosis Are Associated with Adult and Pediatric Systemic Rheumatic Diseases,” investigates how stressful life events impact the likelihood of developing systemic rheumatic diseases (SRDs),...
by telrheum | Apr 30, 2024 | Autoimmune Diseases, Antiphospholipid Antibody Syndrome, Pregnancy
The article titled “Cluster Analysis of Antiphospholipid Antibodies Associated Adverse Pregnancy Outcome Patients: Based on a 13-year Longitudinal Cohort Study” focuses on the effects of antiphospholipid antibodies (aPLs) on pregnancy outcomes. Conducted...
by telrheum | Apr 23, 2024 | Biologic Therapy, Il-6 inhibitors, Infections, JAK Inhibitor
This article, “Risk of Hepatitis B Virus Reactivation in Patients with Rheumatoid Arthritis Receiving JAK Inhibitor or IL-6 Inhibitor: A Systematic Review and Meta-Analysis” by Akhil Sood, Janice Lin, and Neha Shah from Stanford University, presents a study that looks...
by telrheum | Apr 21, 2024 | Biologic Therapy, Immunoglobulins, Infections
The study titled “Risk of Severe Infections Associated with Immunoglobulin Deficiency Under Rituximab Therapy in Immune Mediated Inflammatory Diseases” conducted by Claire Rempenault and colleagues, explored the connection between severe infections and...
by telrheum | Apr 21, 2024 | Lupus, Hydroxychloroquine
The study discussed in the article focuses on the prevalence and risk factors associated with retinal toxicity in patients using hydroxychloroquine (HCQ) for over five years, primarily for autoimmune diseases. This medication is generally safe but has been linked to...
